Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice

Journal of Clinical Investigation

Volumn 121, Issue 5, 2011, Pages 1974-1985

  Fukushima, Yoko ^a,b,c   Okada, Mitsuhiro ^b   Kataoka, Hiroshi ^b   Hirashima, Masanori ^a   Yoshida, Yutaka ^d   Mann, Fanny ^e   Gomi, Fumi ^c   Nishida, Kohji ^c   Nishikawa, Shin Ichi ^b   Uemura, Akiyoshi ^a,b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLEXIN; PLEXIN D1; SEMAPHORIN; SEMAPHORIN 3E; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA ISCHEMIA; RETINOPATHY; SIGNAL TRANSDUCTION;

ANIMALS; ANOXIA; BLOOD VESSELS; CELL ADHESION MOLECULES, NEURONAL; ENDOTHELIAL CELLS; GLYCOPROTEINS; GTP PHOSPHOHYDROLASES; HUMANS; ISCHEMIA; LIGANDS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; NEURONS; PSEUDOPODIA; RETINAL DISEASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955497166     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44900     Document Type: Article

References (49)

1. Friedlander M. Fibrosis and diseases of the eye. J Clin Invest. 2007;117(3):576-586. (Pubitemid 46348512)
2. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005; 438(7070):960-966. (Pubitemid 43093962)
3. Saint-Geniez M, D'Amore PA. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol. 2004;48(8-9):1045-1058. (Pubitemid 40039191)
4. Patz A. Current concepts in ophthalmology. Retinal vascular diseases. N Engl J Med. 1978; 298(26):1451-1454. (Pubitemid 8369676)
5. Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248(7):915-930.
6. Micieli JA, Surkont M, Smith AF. A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity. Am J Ophthalmol. 2009;148(4):536-543.
7. Fruttiger M. Development of the retinal vasculature. Angiogenesis. 2007;10(2):77-88. (Pubitemid 46440628)
8. Uemura A, Kusuhara S, Katsuta H, Nishikawa S. Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp Cell Res. 2006; 312(5):676-683. (Pubitemid 43290344)
9. Gerhardt H, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161(6):1163-1177. (Pubitemid 36870177)
10. Ruhrberg C, et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 2002;16(20):2684-2698.
11. Adams RH, Eichmann A. Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol. 2010;2(5):a001875.
12. Chauvet S, et al. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron. 2007;56(5):807-822. (Pubitemid 350181350)
13. Bellon A, et al. VEGFR2 (KDR/Flk1) signaling mediates axon growth in response to semaphorin 3E in the developing brain. Neuron. 2010;66(2):205-219.
14. Gu C, et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science. 2005;307(5707):265-268. (Pubitemid 40116243)
15. Uesugi K, Oinuma I, Katoh H, Negishi M. Different requirement for Rnd GTPases of R-Ras GAP activity of Plexin-C1 and Plexin-D1. J Biol Chem. 2009; 284(11):6743-6751.
16. Sakurai A, et al. Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol. 2010;30(12):3086-3098.
17. Stone J, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15(7 pt 1):4738-4747.
18. West H, Richardson WD, Fruttiger M. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development. 2005;132(8):1855-1862. (Pubitemid 40691775)
19. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225-230.
20. Moriya J, et al. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis. Circ Res. 2010; 106(2):391-398.
21. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol. 2005; 6(10):789-800. (Pubitemid 41726117)
22. Hall A, Lalli G. Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb Perspect Biol. 2010;2(2):a001818.
23. Puschel AW. GTPases in semaphorin signaling. Adv Exp Med Biol. 2007;600:12-23.
24. Vignal E, et al. Characterization of TCL, a new GTPase of the rho family related to TC10 and Cdc42. J Biol Chem. 2000;275(46):36457-36464.
25. Abe T, Kato M, Miki H, Takenawa T, Endo T. Small GTPase Tc10 and its homologue RhoT induce N-WASP-mediated long process formation and neurite outgrowth. J Cell Sci. 2003;116(pt 1):155-168. (Pubitemid 36113974)
26. Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays. 2007; 29(4):356-370. (Pubitemid 46597867)
27. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol. 2008;9(9):690-701.
28. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108(2):193-199.
29. Xiao C, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008; 9(4):405-414. (Pubitemid 351405110)
30. Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF, Wang R. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol. 2006;172(1):151-162. (Pubitemid 43042637)
31. Egawa G, Osawa M, Uemura A, Miyachi Y, Nishikawa S. Transient expression of ephrin B2 in perinatal skin is required for maintenance of keratinocyte homeostasis. J Invest Dermatol. 2009;129(10):2386-2395.
32. Smith LE, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35(1):101-111. (Pubitemid 24046832)
33. Albuquerque RJ, et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med. 2009;15(9):1023-1030.
34. Shalaby F, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376(6535):62-66.
35. Zhang Y, et al. Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects. Dev Biol. 2009;325(1):82-93.
36. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669-676. (Pubitemid 36749215)
37. Lamalice L, Houle F, Jourdan G, Huot J. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene. 2004;23(2):434-445. (Pubitemid 38174998)
38. Gitler AD, Lu MM, Epstein JA. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell. 2004; 7(1):107-116. (Pubitemid 39172692)
39. Aiello LP, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331(22):1480-1487. (Pubitemid 24356306)
40. Sennlaub F, Courtois Y, Goureau O. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest. 2001;107(6):717-725. (Pubitemid 32225357)
41. Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest. 2007; 117(9):2506-2516. (Pubitemid 47494352)
42. FitzGibbon T. The human fetal retinal nerve fiber layer and optic nerve head: a DiI and DiA tracing study. Vis Neurosci. 1997;14(3):433-447.
43. Dorrell MI, et al. Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia. 2010;58(1):43-54.
44. Roodink I, Verrijp K, Raats J, Leenders WP. Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. BMC Cancer. 2009;9:297.
45. Uemura A, Kusuhara S, Wiegand SJ, Yu RT, Nishikawa S. Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J Clin Invest. 2006; 116(2):369-377. (Pubitemid 43228353)
46. Watakabe A, Ohsawa S, Hashikawa T, Yamamori T. Binding and complementary expression patterns of semaphorin 3E and plexin D1 in the mature neocortices of mice and monkeys. J Comp Neurol. 2006;499(2):258-273. (Pubitemid 44454065)
47. Motoike T, et al. Universal GFP reporter for the study of vascular development. Genesis. 2000; 28(2):75-81.
48. Takebe A, Era T, Okada M, Jakt LM, Kuroda Y, Nishikawa S. Microarray analysis of PDGFR alpha+ populations in ES cell differentiation culture identifies genes involved in differentiation of mesoderm and mesenchyme including ARID3b that is essential for development of embryonic mesenchymal cells. Dev Biol. 2006;293(1):25-37.
49. Jakt LM, Nishikawa S. DNA chip databases, omics, and gene fishing: commentary. Cancer Sci. 2008;99(5):829-835. (Pubitemid 351997582)